For over two decades concerns have been raised internationally about the decline in the number of clinician-scientists. [1] [2] [3] [4] More recently, it has been argued that the principal issue is not the numberof clinician-scientists but rather the number that is engaged in clinical research, specifically, in patientoriented research. 5 In Canada, growth in clinical research funded by the Canadian Institutes for Health Research (CIHR), the government of Canada's health research funding agency, was shown to be slower than growth in other research themes, namely biomedical, population-based health and health services research at multiple levels. 6 The number of clinician-scientists involved in federally-funded patient-oriented research in Canada in the year 1997 was estimated, based on National Institutes of Health (NIH) statistics from the United States, to be fewer than 100 MDs and MD/ PhDs in Canada. 5 Canada is preparing to compete in a knowledgebased global economy, specifically, in the development of an integrated globally competitive Canadian Program in Clinical Research. 7 Now, more than ever, it will be necessary to assess the country's manpower and infrastructure in clinical research and determine the resources needed to enhance Canadian capacity in this area. There are no Canadian data-based statistics on the number of active clinical researchers in the country. The primary objective of the present descriptive study, therefore, was to document retrospectively the number and scope of clinical investigators across Canada using, as an indicator, the funding received for clinical research from the CIHR. A secondary objective was to describe trends in publishing original clinical research articles in Canada.
Materials & Methods
The CIHR Funded-Research database is a publiclyavailable, project-based online database that provides basic information on all funding granted by the CIHR since its inception in 2000. 8 Project commitments made previously by the Medical Research Council of Canada (MRC) and duly honoured by the CIHR are also included in the database, which is comprised of text fields such as principal investigator (PI), supervisor, co-investigator (Co-I), funding program, and research theme. Numerical fields report the amounts funded and date fields include the effective and expiry dates of funding.
CIHR categorizes health research in four broad themes: bio-medical; clinical; social, cultural, environmental and population health; and health services. 9 Clinical research is defined as 'research with the goal of improving the diagnosis, and treatment (including rehabilitation and palliation), of disease and injury; improving the health and quality of life of individuals as they pass through normal life stages; research on, or for the treatment of, patients'. 9 Data on all grants and awards funded under the theme 'clinical research' in fiscal years 1999-00 to 2006-07 were downloaded in November 2007 from the CIHR website. Multiple investigator names, separated by semicolons and embedded in single text fields, were edited in a Microsoft Excel spreadsheet 10 so that the resulting database contained one investigator name per column. From this project-based data structure, an investigator-specific database was built using SAS codes and data steps. 11 For each investigator, the total number of projects funded in the capacity of PI or Co-I; average number of years per funded project; multiple responsibilities held such as PI, supervisor, Co-I or trainee; and different types of awards received were tabulated. Investigator's area(s) of research was assigned based on the Institute(s) through which funding was received. Cumulative research funding (CRF) received by each investigator was calculated as the sum total of all clinical research grant funding received by the individual in the capacity of a PI. For projects with two or more investigators, the funded amounts were split evenly among the listed PIs, irrespective of the number of Co-Is listed on the project. For example, if a project with two PIs and 10 Co-Is was funded a total amount of $100,000, then $50,000 was assigned to each PI. A PI who served as a Co-I on any additional projects was assigned $0 on account of those additional projects. Amounts received as awards, if any, were not included in the CRF.
Provincial affiliation of investigators was determined based on the province of the research institution paid. For projects with more than one investigator, it was assumed that all investigators listed were affiliated with the research institution (province) paid. If an investigator listed on multiple projects appeared to be affiliated with more than one province simultaneously, then the primary research institution (province) of the investigator was located by conducting a search on the internet. If provincial affiliation varied with time, then the investigator contributed to the investigator count in each of the affiliated provinces. Provincial distribution of clinical investigators and clinical research funding was adjusted for the average provincial population in the years 2000-2007, as reported by Statistics Canada, 12 and expressed per million population per province.
ers, were assessed quantitatively by searching the Science Citation Index Expanded (SCI-Expanded) database 13 in January 2008. Publication of original research articles during the time period 2002-2007 was the primary focus of this study but trends from this period were compared with those from two previous periods (1990-1995 and 1996-2001) . Articles with a potential to be clinically relevant were identified through 3 independent searches by using the field tag 'TS' in the Advanced Search feature: TS = clinical; TS = clinical research; TS = clinical medicine. i
Statistical Analyses
Data were summarized using descriptive statistics. Significant differences in population means were determined using T-tests for normally distributed data and Wilcoxon rank sum test for non-parametric data. Correlation between non-normally distributed variables was assessed by calculating Spearman correlation coefficient. Categorical variables were reported using frequency distribution and tested for differential distribution using 2 goodness of fit tests. Statistical significance was determined at P-value < 0.05. Results Four hundred and fifty three research trainees (including 56 trainees who transitioned to an independent, non-trainee role during the study period), overseen by 449 supervisors, received 247 clinical research fellowship awards (distributed among 230 fellows) and 227 clinical research studentship awards (distributed among 223 students). iii,iv Approximately 29 fellows and 28 students per year received clinical research trainee awards. A large number of individuals (n=2,952) served as co-investigators on grants ( Figure  1 ). In all, 3,646 individuals carried out 1 or more types of non-trainee investigator roles. While 709 investigators fulfilled more than 1 type of role, 111 carried out all 3 investigator roles.
Number

Scope
Total funding received for clinical research during the study period was CAD$468,744,744 and represented 11% of the total amount of funding distributed by the CIHR. 8 The majority ($415,393,441 [88.6%]) was received in the form of grants-$254,453,664 (54.3%) for 917 operating grants and $159,959,594 (34.1%) for 195 randomized controlled trials (RCTs). The median amounts of total funding received for operating grants and RCTs (after excluding ongoing projects) were $139,378 and $350,348, respectively. The median number of years of funding per project was 3.
The median number of PIs on all grants was 1 (only 15% of the grants listed >1 PI), but the median number of Co-Is on RCTs was higher than on operat- ing grants (6 vs. 3; P-value < 0.001). Project-level funding was not correlated with the number of PIs listed (Spearman correlation coefficient 'r' = 0.01, Pvalue = 0.74 for operating grants; 'r' = 0.02, -value=0.76 for RCTs) but was correlated with the number of Co-Is ('r' = 0.11, P-value = 0.001 for operating grants; 'r' = 0.35, P-value < 0.0001 for RCTs). Most (764 [73.4%]) of the 1,041 PIs received funding for 1 grant. The median (maximum) CRF received by a single PI, after adjusting for the number of other PIs on each grant, was CAD$154,900 ($15,809,658). Two hundred and nine (20%) PIs received CRF $500,000, while 76 (7.3%) PIs received $1,000,000. Most PIs (806 [77.4%]) received funding for operating grants only but PIs who received funding for both operating grants and RCTs had significantly (P-value < 0.001) higher median CRF ($722,835).
Relatively more PIs and trainees received funding for clinical research in the areas of 'Neurosciences, Mental Health and Addiction' (NMHA) ( Table 1) . NMHA ranked first in the amount of operating grants received ($62,974,436) while 'Circulatory and Respiratory Health' ranked first in the amount of funding received for RCTs ($58,858,726).
Geographic distribution
Quebec had the highest number of PIs (45 per million population) with grants or salary awards for clinical research (Table 2, Figure 2 ). Investigators from British Columbia received more funding for operating grants ($13,100,997 per million population) while those from Ontario received more funding for RCTs ($8,227,362). Ontario also ranked highest in the number of clinical research fellows (10 per million population), while both Quebec and Saskatchewan hosted the highest number of student award recipients (11) . Forty two (55.3%; P-value < 0.0001) of 76 PIs with CRF $1,000,000 were from Ontario; 19 (25.0%) from Quebec; 9 (11.8%) from British Columbia; 3 (3.9%) from Alberta; 2 (2.6%) from Manitoba; and 1 (1.3%) from Nova Scotia. (100) 223 (100) 468744744 * Based on the Institute through which funding was received † Adds up to greater than the total number (100%) of investigators within each column because research area categories were not mutually exclusive. The overview of the scope of clinical research activities across Canada, primarily provided by CIHR funding, was partly illustrated and partly evaluated with supplementary data on number of publications from a parallel time period. Canada's overall ranking in the world with respect to publication productivity in clinically relevant areas remained unchanged over 3 study periods. In pediatrics, an area that benefited from multi-disciplinary, nationally integrated clinical research programs, 7 Canada's ranking in the years 2002 to 2007 was an improvement over its ranking in earlier periods. Perhaps, the pediatrics model could prove to be a successful prototype for future development.
Limitations
The MRC/CIHR is not the only source of research funding in Canada. In 2005-06, other major sources of all biomedical and healthcare research revenues at 16 faculties of medicine in Canada were provincial, regional and municipal government agencies such as Fonds de la recherche en santé du Québec (FRSQ) and Alberta Heritage Foundation for Medical Research (AHFMR); national not-for-profit and charitable organizations such as the Michael Smith Foundation for Health Research (MSFHR); and local community sources including affiliated teaching hospitals such as The Hospital for Sick Children, Toronto. 22 Although what proportion of these revenues went towards clinical research is not known, it is clear that the results of the study do not establish the overall number of clinical researchers in the country or the proportion that is represented by the number of CIHR funded clinical researchers. For the same reason, the number of publications cannot be directly and totally attributed to CIHR funding or correlated with number of CIHR funded researchers. Data on publications may also be considered incomplete as there was likely a potential lag between funding, received towards the tail end of the study period, and corresponding publications. The study does not report the ratio of clinical to basic biomedical researchers.
Our assumption, that trends in CIHR funding can be indicative of trends in regional research activities, can be justified for the following reasons. CIHR is the most prestigious and influential peer-reviewed health research funding agency in Canada. Having contributed 20 -24% of all biomedical and health research revenues received at 16 faculties of medicine in Canada in the years from 1996/97 to 2005/06, CIHR was the single, largest source of revenue for health research in Canadian faculties of medicine in those years. 22 Among past recipients of a specialty-specific research awards program, the CIHR was the most frequently identified source of peer-reviewed grant funding. 23 In conclusion, the previously undocumented number of clinical researchers funded by a major, federal health research funding agency in Canada is alarmingly small. We emphasize caution in interpretation as our analysis does not distinguish between investigator initiated applications and responses to requests for applications; between traditional funding programs and strategic clinical research initiatives; between MD applicants and non-MD applicants; between patientoriented research and other forms of clinical research. Future studies should evaluate the effectiveness of specific initiatives aimed at enhancing the numbers of clinical researchers across Canada.
